These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2369942)
41. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease. Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150 [TBL] [Abstract][Full Text] [Related]
42. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193 [TBL] [Abstract][Full Text] [Related]
43. Survival of patients with polycythemia vera on busulfan or 32P. Mathé G N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270 [No Abstract] [Full Text] [Related]
44. 32P and acute leukemia: development of leukemia in a patient with hemoglobin Yakima. Bagby GC; Richert-Boe K; Koler RD Blood; 1978 Aug; 52(2):350-4. PubMed ID: 667362 [TBL] [Abstract][Full Text] [Related]
45. The effect of different doses of 32P in the treatment of primary thrombocytosis. Randi ML; Fabris F; Varotto L; Peverelli P; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):950-6. PubMed ID: 2419226 [TBL] [Abstract][Full Text] [Related]
46. Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response. Shek PN; Sabiston BH; Buguet A; Radomski MW Int J Sports Med; 1995 Oct; 16(7):466-74. PubMed ID: 8550256 [TBL] [Abstract][Full Text] [Related]
47. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. Khorram O; Yeung M; Vu L; Yen SS J Clin Endocrinol Metab; 1997 Nov; 82(11):3590-6. PubMed ID: 9360512 [TBL] [Abstract][Full Text] [Related]
48. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. Abo T; Cooper MD; Balch CM J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948 [TBL] [Abstract][Full Text] [Related]
49. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Abo T; Miller CA; Balch CM Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709 [TBL] [Abstract][Full Text] [Related]
50. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice. Suzuki S; Suzuki R; Onta T; Kumagai K Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716 [TBL] [Abstract][Full Text] [Related]
51. Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells. Katz P; Mitchell SR; Cupps TR; Evans M; Whalen G Cell Immunol; 1989 Mar; 119(1):130-42. PubMed ID: 2784076 [TBL] [Abstract][Full Text] [Related]
52. Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin-2. Lotzová E; Savary CA; Schachner JR; Huh JO; McCredie K Am J Hematol; 1991 Jun; 37(2):88-99. PubMed ID: 2069169 [TBL] [Abstract][Full Text] [Related]
53. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells. Saiki O; Ralph P Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514 [TBL] [Abstract][Full Text] [Related]
54. Cellular and humoral elements of the lower respiratory tract of sheep. Immunological examination of cells and fluid obtained by bronchoalveolar lavage of normal lungs. Burrells C Vet Immunol Immunopathol; 1985 Nov; 10(2-3):225-43. PubMed ID: 4082477 [TBL] [Abstract][Full Text] [Related]
55. Antilymphocyte globulin therapy enhances impaired function of natural killer cells and lymphokine activated killer cells in aplastic anaemia. Myint AA; Malkovska V; Morgan S; Luckit J; Wonke B; Gordon-Smith EC Br J Haematol; 1990 Aug; 75(4):578-84. PubMed ID: 2207010 [TBL] [Abstract][Full Text] [Related]
56. Suppression of human immunoglobulin synthesis by interleukin-4 in tandem with interleukin-2 through large granular lymphocytes. Bosse D; Ades E Pathobiology; 1991; 59(6):391-5. PubMed ID: 1930692 [TBL] [Abstract][Full Text] [Related]
57. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047 [TBL] [Abstract][Full Text] [Related]
58. Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitus. Gupta S; Charles MA; Waldeck N; Kershnar A; Buckingham B Diabetes Res; 1986 Jun; 3(5):225-9. PubMed ID: 2943547 [TBL] [Abstract][Full Text] [Related]
59. RES scintigraphy in polycythemia vera and secondary or relative polycythemia. Rudberg U; Skårberg KO Acta Radiol; 1993 Mar; 34(2):183-6. PubMed ID: 8452727 [TBL] [Abstract][Full Text] [Related]